Michael Abrams is co-founder and Managing Partner of Numerof & Associates. Over the last 25 years he has built a portfolio of strategy and business performance successes as an internal and external consultant to Fortune 500 corporations.
Leveraging the corporate management experience he acquired prior to founding Numerof, Michael has shaped the development of Numerof’s approach, including the firm’s emphasis on innovative and realistic strategies for changing markets, as well as rigor in managing the complex change necessary for improving organizational performance.
Michael completed his doctoral work in business policy at St. Louis University, received his MA from George Washington University in Washington, D.C., and co-authored Bringing Value to Healthcare: Practical Steps for Getting to a Market-Based Model. He has also contributed articles to more than a dozen leading business journals.
Consolidated healthcare systems – even cross market systems – don’t have to raise their prices to have anticompetitive effects. They can leverage their size by using the volume of their purchases to extract discounts and other concessions from payers, national suppliers, and from labor pools.
The spinoff, however late, promises to make investments in GE more pure plays, which investors find easier to understand and to value. But for GE Healthcare, the real growth will be in less acute settings, and GE needs to acknowledge that trend in their strategy.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In both word and action, the Biden administration has ushered in an aggressive new era of antitrust enforcement. Less than a year in, administration leaders have rescinded previous antitrust guidelines, sometimes without explicit replacement, and stopped pending mergers dead in their tracks. It is difficult to cast judgment on so broad a policy shift, but […]
Until Medicare and commercial insurers link the reimbursement they pay providers to the things that matter to us as consumers and citizens, we will continue to have a dysfunctional system that abides appalling practices like surprise billing, and continue to spend time on band-aids like this interim final rule instead of fixing the real problem.